Srinivas Akkaraju Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity
Srinivas Akkaraju is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 37,887 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $719,853. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
SRINIVAS AKKARAJU Transaction History
Also insider at
SA
Srinivas Akkaraju
Director
Cambridge, MA